Umbralisib tosylate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for umbralisib tosylate and what is the scope of freedom to operate?
Umbralisib tosylate
is the generic ingredient in one branded drug marketed by Tg Theraps and is included in one NDA. There are eight patents protecting this compound. Additional information is available in the individual branded drug profile pages.Umbralisib tosylate has sixty-eight patent family members in thirty-one countries.
Summary for umbralisib tosylate
International Patents: | 68 |
US Patents: | 8 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 9 |
Patent Applications: | 46 |
DailyMed Link: | umbralisib tosylate at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for umbralisib tosylate
Generic Entry Date for umbralisib tosylate*:
Constraining patent/regulatory exclusivity:
Dosage:
TABLET;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Anatomical Therapeutic Chemical (ATC) Classes for umbralisib tosylate
US Patents and Regulatory Information for umbralisib tosylate
International Patents for umbralisib tosylate
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Slovenia | 3260455 | ⤷ Try a Trial | |
Canada | 2949932 | ⤷ Try a Trial | |
Colombia | 7170166 | Inhibidores de pi3k delta selectivos | ⤷ Try a Trial |
China | 111635406 | ⤷ Try a Trial | |
Chile | 2014003511 | Compuesto 2-(1-(4-amino-3-(3-fluoro-4-isopropoxifenil)-1h-pirazolo[3,4-d]pirimidin-1-il)etil)-6-fluoro-3-(3-fluorofenil)-4h-cromen-4-ona y sus sales, inhibidor selectivo de cinasas delta p13k; composicion farmaceutica; uso para tratar una enfermedad o trastorno tal como cancer, trastorno oseo, enfermedad inflamatoria, inmunitaria, metabolica, entre otras. | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2015181728 | ⤷ Try a Trial | |
Eurasian Patent Organization | 201990404 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |